0000899243-22-001650.txt : 20220111
0000899243-22-001650.hdr.sgml : 20220111
20220111211124
ACCESSION NUMBER: 0000899243-22-001650
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220111
DATE AS OF CHANGE: 20220111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vitorovic Stefan
CENTRAL INDEX KEY: 0001826967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525324
MAIL ADDRESS:
STREET 1: C/O PRAXIS PRECISION MEDICINES, INC.
STREET 2: ONE BROADWAY, 16TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-11
0
0001827087
Vigil Neuroscience, Inc.
VIGL
0001826967
Vitorovic Stefan
VIGIL NEUROSCIENCE, INC.
1 BROADWAY, 7TH FLOOR, SUITE 07-300
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2022-01-11
4
C
0
3333245
A
3333245
I
By Vida Ventures III, L.P.
Common Stock
2022-01-11
4
C
0
7684
A
7684
I
By Vida Ventures III-A, L.P.
Common Stock
2022-01-11
4
P
0
1671148
14.00
A
5004393
I
By Vida Ventures III, L.P.
Common Stock
2022-01-11
4
P
0
3852
14.00
A
11536
I
By Vida Ventures III-A, L.P.
Series B Preferred Stock
2022-01-11
4
C
0
9243756
0.00
D
Common Stock
3333245
0
I
By Vida Ventures III, L.P.
Series B Preferred Stock
2022-01-11
4
C
0
21310
0.00
D
Common Stock
7684
0
I
By Vida Ventures III-A, L.P.
Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any.
The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any.
On January 11, 2022, Vida III purchased 1,671,148 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
On January 11, 2022, Vida III-A purchased 3,852 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
/s/Jennifer Ziolkowski, Attorney-in-Fact
2022-01-11